Equity · Healthcare
Is Stryker Corporation (SYK) tradable as a perp? Not yet
Stryker Corporation is a medical technology company with segments in orthopaedics and spine, and MedSurg and neurotechnology, selling implants, surgical equipment, and neurovascular devices to hospitals worldwide.
Price chart
Interactive TradingView chart
TradingView symbol NYSE:SYK
Loads TradingView's third-party widget (about 1 MB) on demand.
Company data
Company fundamentals
Updated 2h ago
Company data
Company fundamentals
More metrics
Fundamental detail
Annual + quarterlyRefreshed 2h ago
Charts: revenue, profit, cash flow & valuation
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsRevenue mix
PendingAnalysts
PendingOwnership
SYK-PERPFilings
PendingTranscripts
PendingLatest updates
PendingAnalyst track record
How the analysts covering SYK have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 156 | 421 |
| Analysts | 36 | 39 |
| Buy / hold / sell | 133 / 23 / 0 | 347 / 74 / 0 |
| Upgrades / downgrades / initiations | 4 / 1 / 5 | 7 / 1 / 9 |
| Price targets hit / missed | 0 / 138 (0%) | 1 / 378 (0%) |
| Avg. return after a rating (TipRanks) | -30.9% | -28.6% |
| Best / worst call | -11.1% / -40.3% | +3.8% / -40.3% |
After buy calls on this stock: median 21-day move +1.2% vs S&P 500 0.0% (n = 340)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Ryan ZimmermanBTIG81% hit rate on this stock · 26 targets measuredBuytarget $358Aug 27, 2026
- Vijay KumarEvercore ISI75% hit rate on this stock · 8 targets measuredBuytarget $350Jul 6, 2026
- Matthew O'BrienPiper Sandler64% hit rate on this stock · 14 targets measuredBuytarget $390Jul 31, 2026
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Sep 18, 2026 | William PlovanicCanaccord Genuity | BuyReiterated | $385 | article ↗ |
| Sep 16, 2026 | Kendall AuRBC Capital | BuyReiterated | $420 | article ↗ |
| Sep 16, 2026 | Larry BiegelsenWells Fargo | BuyReiterated | $348 | article ↗ |
| Sep 15, 2026 | Travis SteedBank of America Securities | BuyReiterated | $380 | article ↗ |
| Sep 16, 2026 | Larry BiegelsenWells Fargo | BuyMaintained | $348 |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data via FMP · computed Sep 18, 2026 · 156 ratings